Extraovular PGE2 and oxytocin-implicated uterine rupture during midtrimester termination of pregnancy.
A case of uterine rupture caused by extraovular PGE2 in a sequence with intravenous oxytocin during midtrimester termination of pregnancy is presented. It teaches us that when oxytocin is used after prostaglandins in patients having a scarred uterus, the lowest effective dose should be applied.
Lurie
S
S
Department of Obstetrics and Gynecology, Kaplan Hospital, Rehovot, Israel.
Hagay
Z
Z
Borenstein
R
R
D000032:Abortion, Therapeutic; D000328:Adult; D015232:Dinoprostone / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D005313:Fetal Death; D006801:Humans; D010121:Oxytocin / Q000008:administration & dosage / Q000009:adverse effects*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D014597:Uterine Rupture / Q000139:chemically induced*
D010121:Oxytocin; D015232:Dinoprostone